The relationship of ST6GAL1 with clinicopathological and prognostic factors in breast carcinomas
This research is one of the first studies to use ST6GAL1 in preoperative biopsies of patients not scheduled for neoadjuvant treatment. This study revealed highly significant associations of ST6GAL1 expression with HR, HER2, and molecular subtyping. Future studies are recommended to clarify the possible role of ST6GAL1 in resistance to HR and HER2-targeted and other chemotherapeutic agents in BCs.
Authors
- Serden Ay (ORCID: https://orcid.org/0000-0001-9198-2342)
- Tuğba Günler (ORCID: https://orcid.org/0000-0001-6319-7304)
- Ethem Ömeroğlu (ORCID: https://orcid.org/0000-0002-4943-6871)
- Sümeyye Kozacıoğlu (ORCID: https://orcid.org/0000-0002-5842-4063)
- İlknur Küçükosmanoğlu (ORCID: https://orcid.org/0000-0002-5181-6152)
Institutions
- Konya Food and Agriculture University (TR)
- Sağlık Bilimleri Üniversitesi (TR)
Publication Details
- Journal
- Saudi Medical Journal
- Published
- 2025-11-01
- DOI
- https://doi.org/10.15537/smj.2025.46.11.20250422
- Primary Topic
- Glycosylation and Glycoproteins Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00